Treatment of Pneumocystis carinii pneumonitis with trimethoprim sulfamethoxazole

W. T. Hughes, S. Feldman, S. K. Sanyal

Research output: Contribution to journalArticle

Abstract

Pneumocystis carinii pneumonitis (PCP) is fatal in 90 to 100% of cases if no treatment is given. Trimethoprim sulfamethoxazole (TMP SMX) was used at one of two dosage levels in the treatment of 20 children with PCP and cancer. Of 14 patients treated with 20 mg TMP 100 mg SMX/kg/d, 12 recovered and 2 died. Treatment of the fatal cases and one of the patients who recovered was supplemented with pentamidine. When six patients were treated with 4 to 7 mg TMP 20 to 35 mg SMX/kg/d, four recovered and two died. Both fatal cases and one of the patients who recovered were also treated with pentamidine. There were no significant adverse effects from TMP SMX.

Original languageEnglish (US)
Pages (from-to)47-50
Number of pages4
JournalCanadian Medical Association journal
Volume112
Issue number13
StatePublished - 1975
Externally publishedYes

Fingerprint

Pneumocystis carinii
Sulfamethoxazole Drug Combination Trimethoprim
Pneumonia
Thymidine Monophosphate
Pentamidine
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment of Pneumocystis carinii pneumonitis with trimethoprim sulfamethoxazole. / Hughes, W. T.; Feldman, S.; Sanyal, S. K.

In: Canadian Medical Association journal, Vol. 112, No. 13, 1975, p. 47-50.

Research output: Contribution to journalArticle

Hughes, W. T. ; Feldman, S. ; Sanyal, S. K. / Treatment of Pneumocystis carinii pneumonitis with trimethoprim sulfamethoxazole. In: Canadian Medical Association journal. 1975 ; Vol. 112, No. 13. pp. 47-50.
@article{9b7aa6e6c9a64ff1a68f171058ece017,
title = "Treatment of Pneumocystis carinii pneumonitis with trimethoprim sulfamethoxazole",
abstract = "Pneumocystis carinii pneumonitis (PCP) is fatal in 90 to 100{\%} of cases if no treatment is given. Trimethoprim sulfamethoxazole (TMP SMX) was used at one of two dosage levels in the treatment of 20 children with PCP and cancer. Of 14 patients treated with 20 mg TMP 100 mg SMX/kg/d, 12 recovered and 2 died. Treatment of the fatal cases and one of the patients who recovered was supplemented with pentamidine. When six patients were treated with 4 to 7 mg TMP 20 to 35 mg SMX/kg/d, four recovered and two died. Both fatal cases and one of the patients who recovered were also treated with pentamidine. There were no significant adverse effects from TMP SMX.",
author = "Hughes, {W. T.} and S. Feldman and Sanyal, {S. K.}",
year = "1975",
language = "English (US)",
volume = "112",
pages = "47--50",
journal = "Canadian Medical Association journal",
issn = "0008-4409",
publisher = "Canadian Medical Association",
number = "13",

}

TY - JOUR

T1 - Treatment of Pneumocystis carinii pneumonitis with trimethoprim sulfamethoxazole

AU - Hughes, W. T.

AU - Feldman, S.

AU - Sanyal, S. K.

PY - 1975

Y1 - 1975

N2 - Pneumocystis carinii pneumonitis (PCP) is fatal in 90 to 100% of cases if no treatment is given. Trimethoprim sulfamethoxazole (TMP SMX) was used at one of two dosage levels in the treatment of 20 children with PCP and cancer. Of 14 patients treated with 20 mg TMP 100 mg SMX/kg/d, 12 recovered and 2 died. Treatment of the fatal cases and one of the patients who recovered was supplemented with pentamidine. When six patients were treated with 4 to 7 mg TMP 20 to 35 mg SMX/kg/d, four recovered and two died. Both fatal cases and one of the patients who recovered were also treated with pentamidine. There were no significant adverse effects from TMP SMX.

AB - Pneumocystis carinii pneumonitis (PCP) is fatal in 90 to 100% of cases if no treatment is given. Trimethoprim sulfamethoxazole (TMP SMX) was used at one of two dosage levels in the treatment of 20 children with PCP and cancer. Of 14 patients treated with 20 mg TMP 100 mg SMX/kg/d, 12 recovered and 2 died. Treatment of the fatal cases and one of the patients who recovered was supplemented with pentamidine. When six patients were treated with 4 to 7 mg TMP 20 to 35 mg SMX/kg/d, four recovered and two died. Both fatal cases and one of the patients who recovered were also treated with pentamidine. There were no significant adverse effects from TMP SMX.

UR - http://www.scopus.com/inward/record.url?scp=0016818611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016818611&partnerID=8YFLogxK

M3 - Article

C2 - 1079469

AN - SCOPUS:0016818611

VL - 112

SP - 47

EP - 50

JO - Canadian Medical Association journal

JF - Canadian Medical Association journal

SN - 0008-4409

IS - 13

ER -